D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SANA holding history
Sana Biotechnology, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SANA overviewAll 13F holders of SANAFull Q2 2026 holdings
- Shares (Q2 2026)
- 40,090
- Value
- $139.9K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 40,090 | $139.9K | <0.1% | +1,420+3.7% | Added | Holders |
| Q1 2026 | 38,670 | $111.4K | <0.1% | −22,230−36.5% | Reduced | Holders |
| Q4 2025 | 60,900 | $247.9K | <0.1% | +60,900 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −20,792−100.0% | Sold out | Holders |
| Q2 2025 | 20,792 | $56.8K | <0.1% | −31,170−60.0% | Reduced | Holders |
| Q1 2025 | 51,962 | $87.3K | <0.1% | +51,962 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −47,347−100.0% | Sold out | Holders |
| Q3 2024 | 47,347 | $197.0K | <0.1% | +47,347 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −254,403−100.0% | Sold out | Holders |
| Q4 2023 | 254,403 | $1.04M | <0.1% | +1,634+0.6% | Added | Holders |
| Q3 2023 | 252,769 | $978.2K | <0.1% | −35,385−12.3% | Reduced | Holders |
| Q2 2023 | 288,154 | $1.72M | <0.1% | −239,030−45.3% | Reduced | Holders |
| Q1 2023 | 527,184 | $1.72M | <0.1% | −99,013−15.8% | Reduced | Holders |
| Q4 2022 | 626,197 | $2.47M | <0.1% | +89,480+16.7% | Added | Holders |
| Q3 2022 | 536,717 | $3.22M | <0.1% | +51,922+10.7% | Added | Holders |
| Q2 2022 | 484,795 | $3.12M | <0.1% | +244,246+101.5% | Added | Holders |
| Q1 2022 | 240,549 | $1.99M | <0.1% | −47,552−16.5% | Reduced | Holders |
| Q4 2021 | 288,101 | $4.46M | <0.1% | +40,512+16.4% | Added | Holders |
| Q3 2021 | 247,589 | $5.58M | <0.1% | +247,589 | New | Holders |